Wordt geladen...
SGLT2 inhibitors act from the extracellular surface of the cell membrane
SGLT2 inhibitors are a new class of drugs that have been recently developed to treat type II diabetes. They lower glucose levels by inhibiting the renal Na(+)/glucose cotransporter SGLT2, thereby increasing the amount of glucose excreted in the urine. Pharmacodynamics studies have raised questions a...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley Periodicals, Inc.
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4208661/ https://ncbi.nlm.nih.gov/pubmed/24973332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.12058 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|